Ivermectin and COVID 19

Ivermectin #indicationsAndDoses Invitro antiviral activity Against a broad range of viruses HIV, dengue, influenza, Zika virus Invitro antiviral, SARS-CoV-2 activity 99.8% reduction in viral RNA after 48 h Worldwide use for treating COVID-19 About 3.7 billion doses of ivermectin have been distributed globally over the past 30 years EVMS CRITICAL CARE COVID-19 MANAGEMENT PROTOCOL Preexposure prophylaxis in high-risk patients Postexposure prophylaxis Symptomatic patients at home Mildly symptomatic patients in hospital Progressive Respiratory symptoms Ivermectin has emerged as the “wonder drug” to prophylaxis and treat COVID-19 Ivermectin inhibits viral replication and has potent anti-inflammatory properties There is the potential for serious drug-drug interaction Additional, studies are urgently required to confirm these very impressive